CompanyGraph
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 5
- ScaleMarket cap is $18.29B, above the global median of $1.18B
- FinancialsAltman Z-Score 2.75: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
18.29BUSDvs all stocks (USD)
Revenue (TTM)
2.03BUSDvs all stocks (USD)
Profit Margin
-28.97%Beta
2.06xvs all stocks
52-Week Change
-7.16%vs all stocks
Market Capitalization
18.29BUSDvs all stocks (USD)
Enterprise Value
18.53BUSDvs all stocks (USD)
Forward P/E
22.88xPrice to Sales (TTM)
8.64xPrice to Book (MRQ)
5.78xEnterprise to Revenue
9.13xEnterprise to EBITDA
126.73xGross Margin
79.56%Profit Margin
-28.97%Operating Margin
-5.18%Return on Assets (TTM)
-3.12%Return on Equity (TTM)
-17.38%Revenue (TTM)
2.03BUSDvs all stocks (USD)
Revenue per Share (TTM)
4.70USDUpdated Sep 28, 2026Quarterly Revenue Growth
23.90%Gross Profit (TTM)
1.54BUSDvs all stocks (USD)
EBITDA (TTM)
89.75MUSDvs all stocks (USD)
Net Income (TTM)
-587.54MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
23.93%Operating Cash Flow (TTM)
553.74MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
599.62MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
258.70MUSDFY2025 · Dec 31, 2025Revenue
1.85BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
477.74MUSDFY2025 · Dec 31, 2025Gross Profit
1.37BUSDFY2025 · Dec 31, 2025Operating Income
-479.05MUSDvs all stocks (USD)
Pre-tax Income
-395.20MUSDFY2025 · Dec 31, 2025Income Tax Expense
6.29MUSDFY2025 · Dec 31, 2025Net Income
-401.49MUSDFY2025 · Dec 31, 2025EBIT
-371.19MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
89.75MUSDFY2025 · Dec 31, 2025Research & Development
929.52MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
921.45MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
107.86MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
24.01MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.9600USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.9600USDFY2025 · Dec 31, 2025Basic Shares Outstanding
420.91MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
420.91MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-401.49MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
-1.27MUSDFY2025 · Dec 31, 2025Operating Cash Flow
351.43MUSDFY2025 · Dec 31, 2025Free Cash Flow
332.41MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.06BUSDFY2025 · Dec 31, 2025Income Tax Paid
10.59MUSDFY2025 · Dec 31, 2025Interest Paid
20.00MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-401.49MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
460.94MUSDFY2025 · Dec 31, 2025Stock-based Compensation
385.21MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-46.43MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-69.08MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-545.00KUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
22.82MUSDFY2025 · Dec 31, 2025Capital Expenditures
-19.02MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-3.00MUSDFY2025 · Dec 31, 2025Purchase of Investments
-2.00MUSDFY2025 · Dec 31, 2025Sale of Investments
0.00USDFY2025 · Dec 31, 2025Net Investing Cash Flow
-21.02MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
690.00MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-641.69MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
0.00USDFY2025 · Dec 31, 2025Other Financing Charges
-57.67MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-9.36MUSDFY2025 · Dec 31, 2025Shares Outstanding
439.99MSharesUpdated Sep 28, 2026Float Shares
369.59MSharesUpdated Sep 28, 2026Shares Short
29.12MSharesUpdated Sep 28, 2026Short Ratio
3.15daysvs all stocks
Short % of Shares Outstanding
6.65%vs all stocks
% Held by Insiders
3.36%vs all stocks
% Held by Institutions
86.55%vs all stocks
Total Cash (MRQ)
2.35BUSDvs all stocks (USD)
Total Cash per Share (MRQ)
5.34USDUpdated Sep 28, 2026Total Debt (MRQ)
2.32BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.7018xCurrent Ratio (MRQ)
2.03xBook Value per Share (MRQ)
6.89USDUpdated Sep 28, 2026Total Assets
6.84BUSDvs all stocks (USD)
Total Current Assets
2.81BUSDFY2025 · Dec 31, 2025Total Liabilities
3.34BUSDFY2025 · Dec 31, 2025Total Non-current Assets
4.03BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
1.82BUSDFY2025 · Dec 31, 2025Total Current Liabilities
1.53BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
2.06BUSDFY2025 · Dec 31, 2025Accounts Receivable
643.61MUSDFY2025 · Dec 31, 2025Accounts Payable
13.98MUSDFY2025 · Dec 31, 2025Short-term Debt
556.45MUSDFY2025 · Dec 31, 2025Deferred Revenue
224.41MUSDFY2025 · Dec 31, 2025Long-term Debt
1.68BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
122.66MUSDFY2025 · Dec 31, 2025Common Stock (Book)
2.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-4.14BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
3.50BUSDvs all stocks (USD)
52-Week Low
16.78USDUpdated Sep 28, 202652-Week High
52.15USDUpdated Sep 28, 202652-Week Change
-7.16%vs all stocks
Beta
2.06xvs all stocks
50-Day MA
40.11USDUpdated Sep 28, 2026200-Day MA
32.08USDUpdated Sep 28, 2026Avg 10-Day Volume
10.34MSharesUpdated Sep 28, 2026Avg 30-Day Volume
9.69MSharesUpdated Sep 28, 2026Diluted EPS (TTM)
-1.36USDUpdated Sep 28, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Diagnostic
High R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Heavy R&D and stock pay, with the share count growing across six years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.80Profit Margin: -0.29
Financial Health
Altman Z-Score 2.75: safe zoneNotable
Altman Z-Score: 2.75
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Market cap is $18.29B, above the global median of $1.18BNotable
Market cap (USD): 18,285,695,166Global Median: 1,180,223,658.953
Revenue is $2.03B, above the global median of $548.88MNotable
Revenue (USD): 2,028,409,984Global Median: 548,883,780.48
Levered free cash flow is $599.62M, above the global median of $18.73MNotable
Levered free cash flow (USD): 599,621,120Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Toast Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowProduction
Godaddy Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowProduction
HubSpot, Inc.
Tier 1InterfaceRecurring-Revenue Lock-InProductionFlow
WiseTech Global Limited
Tier 1InterfaceRecurring-Revenue Lock-InProductionFlow
Procore Technologies Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowSenseMaking
Zeta Global Holdings Corp.
Tier 1InterfaceRecurring-Revenue Lock-InAttentionSenseMaking
The Descartes Systems Group Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowSenseMaking
ServiceTitan, Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowProduction
Navan, Inc.
Tier 1InterfaceRecurring-Revenue Lock-InProductionFlow
Doximity Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
ImmunityBio, Inc.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Iovance Biotherapeutics, Inc.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
AbCellera Biologics Inc.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC